View Older Stories

May 11, 2026 07:31AM Bicara Therapeutics Inc. (BCAX) Reports Q1 Loss of $0.93

May 10, 2026 11:58PM Guggenheim Starts Bicara Therapeutics Inc (BCAX) at Buy

Apr 19, 2026 10:00AM These are the best biotech stocks to own in 2026: BofA

Mar 31, 2026 06:39AM Bicara Therapeutics Inc (BCAX) PT Raised to $42 at H.C. Wainwright

Mar 31, 2026 04:21AM Bicara Therapeutics Inc (BCAX) stock an 'attractive investment opportunity': Analyst

Mar 25, 2026 06:25AM BofA Securities Starts Bicara Therapeutics Inc (BCAX) at Buy

Feb 23, 2026 04:54AM Bicara Therapeutics (BCAX) Reiterated at Market Outperform by Citizens: 'Attractive'

Feb 20, 2026 04:37AM Bicara Therapeutics (BCAX) Reiterated at Market Outperform by Citizens: Attractive

Feb 11, 2026 04:43PM Goldman Sachs Downgrades Bicara Therapeutics Inc (BCAX) to Neutral

Jan 29, 2026 03:09AM Citizens Starts Bicara Therapeutics Inc (BCAX) at Market Outperform

Jan 15, 2026 09:04AM BTIG Reiterates Buy Rating on Bicara Therapeutics Inc (BCAX)

Jan 14, 2026 06:56AM H.C. Wainwright Reiterates Buy Rating on Bicara Therapeutics Inc (BCAX)

Jan 8, 2026 06:08AM BTIG Starts Bicara Therapeutics Inc (BCAX) at Buy

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 21, 2025 08:00PM Here's the list of top biotech stocks to own for 2026

Dec 17, 2025 04:04PM Mizuho Starts Bicara Therapeutics Inc (BCAX) at Neutral

Dec 8, 2025 07:33AM Bicara's (BCAX) ESMO-Asia Presentation Encouraging - Stifel

Nov 10, 2025 05:17PM Bicara Therapeutics Inc. (BCAX) Reports Q3 Loss of $0.67

Oct 21, 2025 07:27AM Stifel Reiterates Bicara Therapeutics Inc (BCAX) at Buy, Still Confident of Ficerafusp Thesis

Oct 14, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Bicara Therapeutics Inc (BCAX)

Oct 13, 2025 07:31AM FDA grants breakthrough therapy designation to Bicara's cancer drug

Oct 3, 2025 04:36PM Bicara Therapeutics (BCAX) files $400M mixed shelf

Sep 30, 2025 08:42AM TD Cowen: 'Bicara Therapeutics Inc (BCAX) Remains An Attractive Investment'

Sep 9, 2025 07:16AM Jones Trading Starts Bicara Therapeutics Inc (BCAX) at Buy

Aug 22, 2025 06:52AM Bicara Therapeutics Inc (BCAX) PT Lowered to $40 at H.C. Wainwright

Aug 19, 2025 06:13AM Piper Sandler Starts Bicara Therapeutics Inc (BCAX) at Overweight

Jun 11, 2025 04:07PM Relay Therapeutics (RLAY) appoints Claire Mazumdar to Board

Jun 9, 2025 07:27AM Stifel Reiterates Buy Rating on Bicara Therapeutics Inc (BCAX)

Jun 3, 2025 07:03AM Cantor Fitzgerald Reiterates Overweight Rating on Bicara Therapeutics Inc (BCAX)

Jun 2, 2025 07:08AM Stifel Reiterates Buy Rating on Bicara Therapeutics Inc (BCAX)

Jun 2, 2025 06:50AM Cantor Fitzgerald Reiterates Overweight Rating on Bicara Therapeutics Inc (BCAX)

May 23, 2025 07:39AM Stifel Reiterates Buy Rating on Bicara Therapeutics Inc (BCAX)

May 22, 2025 05:12PM Bicara Therapeutics (BCAX) publishes updated data from Phase 1/1b trial of Ficerafusp alfa

May 19, 2025 09:18AM TD Cowen: 'Risk/Reward for Bicara Therapeutics Inc (BCAX) into ASCO is Great'

May 16, 2025 06:43AM Bicara Therapeutics Inc (BCAX) PT Lowered to $41 at H.C. Wainwright

May 13, 2025 04:31PM Bicara Therapeutics Inc. (BCAX) Reports Q1 Loss of $0.68

Apr 23, 2025 10:02AM Bicara Therapeutics (BCAX) present updated data for Ficerafusp alfa in 1L trial

Apr 17, 2025 05:43AM Wells Fargo Starts Bicara Therapeutics (BCAX) at Underweight

Apr 7, 2025 06:39AM Bicara Therapeutics Inc (BCAX) PT Lowered to $44 at H.C. Wainwright

Mar 31, 2025 07:44AM Cantor Fitzgerald Reiterates Overweight Rating on Bicara Therapeutics Inc (BCAX)

Mar 27, 2025 01:50PM Bicara Therapeutics Inc (BCAX) PT Raised to $48 at Stifel

Mar 17, 2025 07:06AM Cantor Fitzgerald says 15% of biotech companies down 40% or more

Mar 13, 2025 06:46AM Cantor Fitzgerald Reiterates Overweight Rating on Bicara Therapeutics Inc (BCAX)

Feb 11, 2025 04:02PM Bicara Therapeutics Announces First Patients Enrolled in FORTIFI-HN01

Jan 27, 2025 09:33AM Stifel Reiterates Buy Rating on Bicara Therapeutics Inc (BCAX)

Jan 27, 2025 08:18AM Bicara Therapeutics (BCAX) Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers Symposium

Jan 27, 2025 08:01AM Bicara Therapeutics (BCAX) Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa

Jan 27, 2025 07:13AM Bicara Therapeutics Inc (BCAX) PT Raised to $45 at H.C. Wainwright

Nov 5, 2024 06:39AM Rodman and Renshaw Starts Bicara Therapeutics Inc (BCAX) at Buy

Oct 8, 2024 06:36AM Cantor Fitzgerald Starts Bicara Therapeutics Inc (BCAX) at Overweight

View Older Stories